Community Health Interventions | Thalassemia
page-template-default,page,page-id-16394,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.4.5,vc_responsive


What Should You Know About Thalassemia?

Thalassemia is a group of genetic blood disorders that affect approximately 1,000 individuals in the United States. The most severe of these disorders is Cooley’s Anemia.


People with thalassemia have a genetic defect of their red blood cells that affects the cells’ ability to produce normal hemoglobin. Red blood cells use hemoglobin to carry oxygen to tissues. As a result of the defect, most forms of thalassemia produce a chronic, lifelong anemia that begins in early childhood and often must be treated with frequent transfusions.


Prevention Activities

CDC is developing a new program to establish a surveillance system to monitor blood safety for thalassemia patients, establish a network of specialized health-care centers to promote the management, treatment, and prevention of complications experienced by persons with thalassemia. For more information?




  • National Heart Lung and Blood Institute
  • Cooley’s Anemia Foundation icon
  • Thalassaemia International Federation
  • Kids Health
  • Related Pages
  • Deep Vein Thrombosis (DVT) and Clotting
  • Diamond Blackfan Anemia
  • Hemochromatosis (Iron Overload)
  • Hemophilia
  • Sickle Cell Disease
  • Women’s Blood Disorders
  • CDC’s National Center on Birth Defects and Developmental Disabilities


Content source: Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention